Gene Therapy

As gene therapy developers progress through the clinical phases to commercial manufacture, additional capacity may be required resulting in the need to move to a new facility or invest in a build program. The DPS team has been designing these advanced facilities since the first gene therapy revolution in the late 1990s and brings many years of experience in the successful delivery of clinical and commercial facilities for our clients.

We understand our clients’ challenges in viral vector production and the evolving platforms for these highly complex molecules. We understand the challenges in building robust processes under tight schedules.

Let us share the best current strategies in flexible facilities, addressing rapid deployment needs while navigating the regulatory pathway to facility licensure. Contact us now to discuss your next gene therapy project.

Tell us about your project

and discover how DPS can help you today

Project Profiles
Brammer Bio, Gene Therapy cGMP Manufacturing and QC Operations Facility
DPS provided detailed design services to assist Brammer in developing a new cGMP manufacturing and QC operations facility.
Brammer Bio, Viral Vector Manufacturing Facility
Having successfully completed several gene therapy projects, Brammer Bio hired DPS to work on the renovation and expansion of its GMP facility.
CSL Behring, Multi-Purpose Biologics Facility (MPF)
CSL plan to build a Multi-Purpose Biologics Facility (MFP) to support their manufacturing strategy; particularly to develop and support growth in gene and cell therapy.
Homology, Viral Vector Manufacturing Facility & QC Operations
To support its rapid transition into clinical development, the client is planning to build a new cGMP Manufacturing/ Pilot and QC Operations facility.
Janssen, Viral Vector Production Facility
DPS Group developed a concept design for a large scale EMEA viral vector production facility in Sassenheim, the Netherlands.
Replimune, Clinical Manufacturing Facility
DPS was hired to provide engineering and design services for a new cGMP manufacturing facility having completed the process definition and test fit phases.
Private: Samsung Biologics, Multimodality ATMP Facility
DPS was commissioned to carry out a concept design study for a new Multimodal Production & Development Facility in Song-do, Incheon, South Korea for the manufacture of multi-platform viral vectors, plasmid DNA and monoclonal antibodies.
South Korea
Sarepta Therapeutics, Gene Therapy Centre of Excellence and Manufacturing Network
Sarepta Therapeutics, Gene Therapy Centre of Excellence and Manufacturing Network
Vertex, Gene / Cell Therapy Manufacturing Facility
DPS was engaged to assist Vertex in determining feasibility to build a multi-product, flexible Gene / Cell Therapy Manufacturing facility in Massachusetts.